시장보고서
상품코드
1663131

국소 진통제 시장 규모, 점유율, 성장 분석 : 치료 클래스별, 제형별, 성별, 연령층별, 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)

Topical Pain Relief Market Size, Share, and Growth Analysis, By Therapeutic Classes (Non-opioids, Opioids), By Formulation (Cream, Gel), By Gender, By Age Group, By Type, By Distribution Channel, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

국소 진통제 세계 시장 규모는 2023년에 112억 달러로 평가되었고, 예측 기간(2025-2032년) 동안 7.3%의 연평균 복합 성장률(CAGR)로 2024년 120억 2,000만 달러에서 2032년에는 211억 2,000만 달러로 성장할 것으로 예상됩니다.

관절염의 유병률 증가는 노인 인구 증가와 운동선수들의 사용 증가와 함께 국소 진통제 시장의 성장을 가속하는 주요 요인으로 작용하고 있습니다. 종합적인 세계 시장 보고서에 따르면, 관절염, 뼈 질환, 당뇨병성 신경병증, 암으로 인한 불편감 등의 사례가 증가함에 따라 이 산업은 큰 추진력을 보이고 있습니다. 국소 진통제 제품은 경구용 약품에 비해 부작용이 적다는 장점이 있습니다. 그러나 잠재적인 피부 자극과 불쾌한 냄새와 같은 문제는 시장 발전을 저해할 수 있습니다. 그럼에도 불구하고 온라인 유통 채널의 성장과 신흥국 시장의 미개발은 시장 확대의 유망한 기회로 작용하고 있습니다. 이러한 진화하는 상황은 국소 진통제 분야의 과제와 잠재적 성장 경로를 강조하고 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter의 Five Forces 분석

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 사례 연구
  • 고객과 구매 기준 분석
  • 규제 분석

국소 진통제 시장 규모 : 치료 클래스별 & CAGR(2025-2032년)

  • 시장 개요
  • 비오피오이드
    • 비스테로이드성 항염증제(NSAID)
    • 메틸살리실산
    • 캡사이신
    • 리도카인
    • 기타 비오피오이드
  • 오피오이드
    • Buprenorphine
    • Fentanyl

국소 진통제 시장 규모 : 제형별&CAGR(2025-2032년)

  • 시장 개요
  • 크림
  • 스프레이
  • 패치
  • 기타

국소 진통제 시장 규모 : 성별&CAGR(2025-2032년)

  • 시장 개요
  • 여성
  • 남성

국소 진통제 시장 규모 : 연령층별&CAGR(2025-2032년)

  • 시장 개요
  • 성인(18-64세)
  • 노인(65세 이상)

국소 진통제 시장 규모 : 유형별&CAGR(2025-2032년)

  • 시장 개요
  • 처방 진통제
  • 시판 진통제

국소 진통제 시장 규모 : 유통 채널별&CAGR(2025-2032년)

  • 시장 개요
  • 약국 및 드럭스토어
  • 소매점
  • 온라인 스토어

국소 진통제 시장 규모& CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업 개요
    • 기업 상세
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 전년대비 매출 비교(2022-2024년)

주요 기업 개요

  • Johnson & Johnson(United States)
  • GlaxoSmithKline plc(United Kingdom)
  • Novartis AG(Switzerland)
  • Pfizer Inc.(United States)
  • Reckitt Benckiser Group plc(United Kingdom)
  • Sun Pharmaceutical Industries Ltd.(India)
  • Endo International plc(Ireland)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Sanofi S.A.(France)
  • Mylan N.V.(now part of Viatris Inc.)(United States)
  • AdvaCare Pharma(United States)
  • Topical Biomedics Inc.(United States)

결론과 제안

LSH 25.03.31

Global Topical Pain Relief Market size was valued at USD 11.2 billion in 2023 and is poised to grow from USD 12.02 billion in 2024 to USD 21.12 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The rising prevalence of arthritis is a key factor driving the growth of the topical pain relief market, alongside an expanding elderly population and increased use among athletes. According to a comprehensive global market report, the industry experiences significant momentum due to rising cases of arthritis, bone disorders, diabetic neuropathy, and cancer-associated discomfort. Topical pain relief products are favored for their reduced side effects compared to oral medications. However, challenges such as potential skin irritation and unpleasant odors could hinder market progress. Nevertheless, the growth of online distribution channels and untapped markets in developing regions present promising opportunities for expansion. This evolving landscape highlights both the challenges and potential avenues for growth in the topical pain relief sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The increasing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, serves as a significant catalyst for the growth of the global topical pain relief market. As more individuals experience these persistent health issues, there is an rising demand for effective, localized pain management options. Consumers are increasingly inclined towards solutions that provide both convenience and targeted relief, which topical treatments can offer. This trend highlights the importance of developing innovative and user-friendly products that cater to the specific needs of patients, driving market expansion and creating opportunities for companies in this sector.

Restraints in the Global Topical Pain Relief Market

Although topical pain relief products are commonly utilized, a significant restraint in the global market lies in the lack of comprehensive clinical evidence supporting their efficacy and safety. This gap in research affects consumer trust and can hinder the widespread adoption of these products. The uncertainty surrounding their performance may lead potential users to seek alternative pain relief options, thereby limiting market growth. Strengthening clinical trials and providing clearer data on the effectiveness and safety profiles of topical pain relief formulations are essential strategies that need to be addressed to enhance consumer confidence and encourage greater market acceptance.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the use of natural and herbal ingredients in its products, driven by a growing consumer preference for wellness-oriented solutions. As awareness of the potential side effects associated with synthetic components rises, more individuals are seeking topical pain relief options that prioritize natural formulations. This shift is not only indicative of a broader demand for cleaner, greener health products but also reflects an emerging inclination towards holistic approaches to pain management. Consequently, manufacturers are pivoting to incorporate organic, plant-based ingredients, aligning with consumer interests in sustainability and superior health benefits.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer And Buying Criteria Analysis
  • Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2025-2032)

  • Market Overview
  • Non-opioids
    • Nonsteroidal anti-inflammatory drug (NSAIDS)
    • Methyl salicylates
    • Capsaicin
    • Lidocaine
    • Other non-opioids
  • Opioids
    • Buprenorphine
    • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2025-2032)

  • Market Overview
  • Cream
  • Gel
  • Spray
  • Patch
  • Others

Global Topical Pain Relief Market Size by Gender & CAGR (2025-2032)

  • Market Overview
  • Women
  • Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Adults (18-64 Years)
  • Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Prescription Pain Relief
  • Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Pharmacy and Drug Stores
  • Retail Stores
  • Online Stores

Global Topical Pain Relief Market Size & CAGR (2025-2032)

  • North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • US
    • Canada
  • Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endo International plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (now part of Viatris Inc.) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdvaCare Pharma (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Topical Biomedics Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제